Moderna Retained Earnings (Accumulated Deficit) 2017-2025 | MRNA
Moderna retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $9.074B, a 27.01% decline year-over-year.
- Moderna retained earnings (accumulated deficit) for 2024 were $10.045B, a 26.17% decline from 2023.
- Moderna retained earnings (accumulated deficit) for 2023 were $13.606B, a 25.73% decline from 2022.
- Moderna retained earnings (accumulated deficit) for 2022 were $18.32B, a 83.97% increase from 2021.